Peng He
8PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 27, 2025
Discovery of a Novel CRBN-Recruiting cGAS PROTAC Degrader for the Treatment of Ulcerative Colitis.Peng He, Chengming Wen, Xinyu Zhang
|Apr 01, 2024
Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment.Huang Chen, Aiwu Bian, Wenbo Zhou
|May 22, 2023
Discovery of Pyrimidinediamine Derivatives as Potent Methuosis Inducers for the Treatment of Triple-Negative Breast Cancer.Jia He, Luzhen Wang, DaZhao Mi
|May 02, 2023
Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance.Peng He, Juanjuan Feng, Xinting Xia
|Oct 25, 2022
Discovery of a Highly Potent and Orally Bioavailable STAT3 Dual Phosphorylation Inhibitor for Pancreatic Cancer Treatment.Peng He, Aiwu Bian, Ying Miao
|Sep 14, 2022
Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr<sup>705</sup>/Ser<sup>727</sup> Inhibitory Activity for Gastric Cancer Treatment.Peng He, Ying Miao, Yue Sun
Pageof 2
Frequent Collaborators
7 joint publications
Yihua Chen
5 joint publications
Mingyao Liu
5 joint publications
Zhengfang Yi
3 joint publications
Haijun Gu
2 joint publications
Qiansen Zhang
2 joint publications
Yangrui Peng
2 joint publications
Xiufeng Pang
1 joint publications
Weikai Guo
1 joint publications
Yajing Xing
1 joint publications
Hang Yin
